0 CHECKOUT

PRODUCT FILTERS

REGION

71
36
35
34
34

COUNTRY

32
4
3
2
1

CATEGORIES

  • 21
  • 11
  • 7
  • 7
  • 6
  • 6
  • 5
  • 4
  • 4
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL

PRICE

6
22
29
124

PUBLISHED

2
9
54
124

PRODUCT TYPE

124

Search for: "China Diabetes Market Report & Outlook For 2010-2015"

China Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics

"China currently has the highest number of diabetics in the world. The disease has presently reached epidemic proportions in the adult population. Around three decades ago, less than one percent of...

Published:  November 2015
Price:  From

Global Diabetes Market Report: 2015 Edition

Diabetes mellitus, or simply diabetes, is a chronic disease that occurs when the pancreas is no longer able to make insulin, or when the body cannot make good use of the insulin it produces. Insulin...

Published:  October 2015
Price:  From

Investigation Report on China's Metformin Market, 2010-2019

According to the statistics of International Diabetes Federation (IDF), in 2013, the prevalence of diabetes among adults aged from 20 to 79 was 8.3% and the number of diabetes patients reached 382 million...

Published:  July 2015
Price:  From

Investigation Report on China's Metformin Market, 2010-2019

According to the statistics of International Diabetes Federation (IDF), in 2013, the prevalence of diabetes among adults aged from 20 to 79 was 8.3% and the number of diabetes patients reached 382 million...

Published:  July 2015
Price:  From

Investigation Report on China's Insulin Aspart Market, 2010-2019

In 2012, diabetes was reported for an estimated 1.5 million cases of death, among of which over 80% were in the middle income and low income countries. And WHO made a prediction that diabetes will become...

Published:  July 2015
Price:  From

Investigation Report on China's Insulin Aspart Market, 2010-2019

In 2012, diabetes was reported for an estimated 1.5 million cases of death, among of which over 80% were in the middle income and low income countries. And WHO made a prediction that diabetes will become...

Published:  July 2015
Price:  From

Investigation Report on China's Repaglinide Market, 2010-2019

According to the statistics of International Diabetes Federation (IDF), in 2013, the prevalence of diabetes among adults aged from 20 to 79 was 8.3% and the number of diabetes patients has reached 382...

Published:  July 2015
Price:  From

Investigation Report on China's Repaglinide Market, 2010-2019

According to the statistics of International Diabetes Federation (IDF), in 2013, the prevalence of diabetes among adults aged from 20 to 79 was 8.3% and the number of diabetes patients reached 382 million...

Published:  July 2015
Price:  From

Investigation Report on China's Acarbose Market, 2010-2019

Diabetes is one of the most important chronic non- communicable diseases that threaten the health of people around the world. According to the statistics of International Diabetes Federation (IDF),...

Published:  May 2015
Price:  From

Investigation Report on China's Acarbose Market, 2010-2019

Diabetes is one of the most important chronic non-communicable diseases that threaten the health of people around the world. According to the statistics of International Diabetes Federation (IDF), in...

Published:  May 2015
Price:  From

Investigation Report on China's Insulin Glargine Market, 2010-2019

According to the statistics of International Diabetes Federation (IDF), in 2013, the prevalence of diabetes among adults aged from 20 to 79 was 8.3% and the number of diabetes patients reached 382 million...

Published:  May 2015
Price:  From

Investigation Report on China's Insulin Glargine Market, 2010-2019

According to the statistics of International Diabetes Federation (IDF), in 2013, the prevalence of diabetes among adults aged from 20 to 79 was 8.3% and the number of diabetes patients reached 382 million...

Published:  May 2015
Price:  From

Investigation Report on China's Glipizide Market, 2010-2019

According to the statistics of the International Diabetes Federation (IDF), in 2013, the prevalence of diabetes among adults aged from 20 to 79 was 8.3% and the number of diabetes patients reached 382...

Published:  July 2015
Price:  From

Investigation Report on China's Glipizide Market, 2010-2019

According to the statistics of the International Diabetes Federation (IDF), in 2013, the prevalence of diabetes among adults aged from 20 to 79 was 8.3% and the number of diabetes patients reached 382...

Published:  July 2015
Price:  From

Investigation Report on China's Glimepiride Market, 2010-2019

According to the statistics of International Diabetes Federation (IDF), in 2013, the prevalence of diabetes among adults aged from 20 to 79 was 8.3% and the number of diabetes patients has reached 382...

Published:  July 2015
Price:  From

Investigation Report on China's Glimepiride Market, 2010-2019

According to the statistics of International Diabetes Federation (IDF), in 2013, the prevalence of diabetes among adults aged from 20 to 79 was 8.3% and the number of diabetes patients has reached 382...

Published:  July 2015
Price:  From

Investigation Report on China's Gliclazide Market, 2010-2019

According to the statistics of International Diabetes Federation (IDF), in 2013, the prevalence of diabetes among adults aged from 20 to 79 was 8.3% and the number of diabetes patients has reached 382...

Published:  July 2015
Price:  From

Investigation Report on China's Nateglinide Market, 2010-2019

According to the statistics of International Diabetes Federation (IDF), in 2013, the prevalence of diabetes among adults aged from 20 to 79 was 8.3% and the number of diabetes patients reached 382 million...

Published:  July 2015
Price:  From

BRIC Diabetes Drugs Market (2010-2015)

The prevalence of diabetes is on the rise across the globe due to increased life expectancy, changing lifestyles, and the rising incidence of obesity Brazil's diabetes drugs market is showing a double...

Published:  April 2010
Price:  From

Investigation Report on China's Liraglutide Market, 2011-2019

As the economy develops and living standards improve, the Chinese people’s dietary pattern changes, resulting in excess eating. Meanwhile, the drop in physical activities leads to the increased obesity...

Published:  June 2015
Price:  From
Loading Indicator

Our Clients

  • Glanbia Plc.
  • Unilever N.V.
  • Microsoft Corporation
  • Duke University
  • A.T. Kearney
  • PepsiCo Inc.
  • Boston Consulting Group